Viet Nam vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB
Viet Nam
100.0%
in 2024
Western Pacific (WHO region)
86.0%
in 2024
Viet Nam rank
1st
Western Pacific (WHO region) rank
3rd
Previously treated cases tested for RR-/MDR-TB over time
- Viet Nam
- Western Pacific (WHO region)
How they compare
Viet Nam currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.
That makes Viet Nam's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 5 times across 12 shared years of data; in 2013 it was Western Pacific (WHO region) ahead.
Viet Nam ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Viet Nam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Viet Nam | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.1% | 75.6% | 10.6% | Viet Nam |
| 2020s | 93.6% | 89.2% | 4.4% | Viet Nam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Viet Nam or Western Pacific (WHO region)?
- Viet Nam, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Viet Nam and Western Pacific (WHO region)?
- 14.0%, with Viet Nam ahead.
- How many years of comparable data are there for Viet Nam and Western Pacific (WHO region)?
- 12 years are reported by both, from 2013 to 2024.
- How do Viet Nam and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Viet Nam ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.